Titan Pharmaceuticals Stock Today
| TTNP Stock | USD 7.10 0.16 2.20% |
Performance5 of 100
| Odds Of DistressOver 80
|
Titan Pharmaceuticals is selling at 7.10 as of the 18th of April 2024; that is -2.2% down since the beginning of the trading day. The stock's last reported lowest price was 7.1. Titan Pharmaceuticals has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Titan Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 19th of March 2024 and ending today, the 18th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 18th of January 1996 | Category Healthcare | Classification Health Care |
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. The company was incorporated in 1992 and is based in South San Francisco, California. Titan Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 914.23 K outstanding shares of which 3.91 K shares are at this time shorted by private and institutional investors with about 0.33 trading days to cover. More on Titan Pharmaceuticals
Moving together with Titan Stock
| 0.74 | EQ | Equillium Financial Report 9th of May 2024 | PairCorr |
Moving against Titan Stock
| 0.59 | DRTS | Alpha Tau Medical Financial Report 28th of May 2024 | PairCorr |
| 0.59 | SABSW | SAB Biotherapeutics | PairCorr |
| 0.57 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.54 | ME | 23Andme Holding | PairCorr |
| 0.54 | VALN | Valneva SE ADR Financial Report 2nd of May 2024 | PairCorr |
| 0.52 | VCYT | Veracyte Financial Report 2nd of May 2024 | PairCorr |
| 0.49 | KA | Kineta Inc Financial Report 9th of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Titan Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Titan Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Titan Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | Marc Rubin | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Titan Pharmaceuticals report their recommendations after researching Titan Pharmaceuticals' financial statements, talking to executives and customers, or listening in on Titan Pharmaceuticals' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Titan Pharmaceuticals. The Titan consensus assessment is calculated by taking the average forecast from all of the analysts covering Titan Pharmaceuticals. | ||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Titan Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Titan Pharmaceuticals may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. Financial strength of Titan Pharmaceuticals is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||
Titan Pharmaceuticals' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Titan Pharmaceuticals' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Titan Pharmaceuticals' financial leverage. It provides some insight into what part of Titan Pharmaceuticals' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
Titan Pharmaceuticals (TTNP) is traded on NASDAQ Exchange in USA. It is located in 400 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 and employs 4 people. Titan Pharmaceuticals is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.63 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Titan Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Titan Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Titan Pharmaceuticals conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 914.23 K outstanding shares of which 3.91 K shares are at this time shorted by private and institutional investors with about 0.33 trading days to cover.
Titan Pharmaceuticals currently holds about 6.42 M in cash with (7.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44.
Check Titan Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationTitan Pharmaceuticals maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months.
Check Titan Ownership Details
Titan Stock Price Odds Analysis
In regard to a normal probability distribution, the odds of Titan Pharmaceuticals jumping above the current price in 90 days from now is about 42.18%. The Titan Pharmaceuticals probability density function shows the probability of Titan Pharmaceuticals stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Titan Pharmaceuticals has a beta of -1.1919. This usually implies as returns on its benchmark rise, returns on holding Titan Pharmaceuticals are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Titan Pharmaceuticals is expected to outperform its benchmark. Additionally, titan Pharmaceuticals has an alpha of 0.3703, implying that it can generate a 0.37 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Titan Pharmaceuticals to move above the current price in 90 days from now is about 42.18 (This Titan Pharmaceuticals probability density function shows the probability of Titan Stock to fall within a particular range of prices over 90 days) .
Titan Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Titan Pharmaceuticals that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Titan Pharmaceuticals' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Titan Pharmaceuticals' value.| Instituion | Recorded On | Shares | |
| Wells Fargo & Co | 2023-09-30 | 84.0 | |
| Blackrock Inc | 2023-09-30 | 60.0 | |
| Advisor Group Holdings, Inc. | 2023-09-30 | 50.0 | |
| Global Wealth Strategies & Associates | 2023-12-31 | 40.0 | |
| Morgan Stanley - Brokerage Accounts | 2023-09-30 | 16.0 | |
| Westside Investment Management, Inc. | 2023-09-30 | 4.0 | |
| Ubs Group Ag | 2023-09-30 | 4.0 | |
| Qube Research & Technologies | 2023-09-30 | 4.0 | |
| Mcclarren Financial Advisors, Inc. | 2023-09-30 | 3.0 | |
| Bb&t Corp. | 2023-09-30 | 625.1 K | |
| Renaissance Technologies Corp | 2023-09-30 | 135.7 K |
Titan Pharmaceuticals Historical Income Statement
Titan Pharmaceuticals Income Statement is one of the three primary financial statements used for reporting Titan's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Titan Pharmaceuticals revenue and expense. Titan Pharmaceuticals Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Titan Pharmaceuticals' Other Operating Expenses is relatively stable compared to the past year. As of 04/18/2024, Total Operating Expenses is likely to grow to about 13 M, while Total Revenue is likely to drop slightly above 174.8 K. View More FundamentalsTitan Stock Against Markets
Picking the right benchmark for Titan Pharmaceuticals stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Titan Pharmaceuticals stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Titan Pharmaceuticals is critical whether you are bullish or bearish towards Titan Pharmaceuticals at a given time. Please also check how Titan Pharmaceuticals' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Titan Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
| All Next | Launch Module |
Titan Pharmaceuticals Corporate Directors
Titan Pharmaceuticals corporate directors refer to members of a Titan Pharmaceuticals board of directors. The board of directors generally takes responsibility for the Titan Pharmaceuticals' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Titan Pharmaceuticals' board members must vote for the resolution. The Titan Pharmaceuticals board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Rajinder Kumar | Director | Profile | |
| James McNab | Director | Profile | |
| Federico Recli | Director | Profile | |
| David MacFarlane | Independent Director | Profile |
How to buy Titan Stock?
Before investing in Titan Pharmaceuticals, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Titan Pharmaceuticals. To buy Titan Pharmaceuticals stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Titan Pharmaceuticals. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Titan Pharmaceuticals stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Titan Pharmaceuticals stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Titan Pharmaceuticals stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Titan Pharmaceuticals, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Titan Stock please use our How to Invest in Titan Pharmaceuticals guide.
Already Invested in Titan Pharmaceuticals?
The danger of trading Titan Pharmaceuticals is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Titan Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Titan Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Titan Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Titan Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Titan Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Titan Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Titan Pharmaceuticals Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Titan Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Titan Stock, please use our How to Invest in Titan Pharmaceuticals guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Titan Stock analysis
When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |
Is Titan Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Titan Pharmaceuticals. If investors know Titan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Titan Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.41) | Revenue Per Share 0.245 | Quarterly Revenue Growth (1.00) | Return On Assets (0.75) | Return On Equity (1.39) |
The market value of Titan Pharmaceuticals is measured differently than its book value, which is the value of Titan that is recorded on the company's balance sheet. Investors also form their own opinion of Titan Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Titan Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Titan Pharmaceuticals' market value can be influenced by many factors that don't directly affect Titan Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Titan Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Titan Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Titan Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.